全文获取类型
收费全文 | 476篇 |
免费 | 38篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 8篇 |
妇产科学 | 6篇 |
基础医学 | 97篇 |
口腔科学 | 9篇 |
临床医学 | 45篇 |
内科学 | 80篇 |
皮肤病学 | 12篇 |
神经病学 | 52篇 |
特种医学 | 13篇 |
外科学 | 31篇 |
综合类 | 3篇 |
一般理论 | 2篇 |
预防医学 | 46篇 |
眼科学 | 15篇 |
药学 | 47篇 |
中国医学 | 4篇 |
肿瘤学 | 47篇 |
出版年
2024年 | 1篇 |
2023年 | 10篇 |
2022年 | 13篇 |
2021年 | 40篇 |
2020年 | 16篇 |
2019年 | 17篇 |
2018年 | 27篇 |
2017年 | 10篇 |
2016年 | 26篇 |
2015年 | 26篇 |
2014年 | 37篇 |
2013年 | 40篇 |
2012年 | 45篇 |
2011年 | 47篇 |
2010年 | 22篇 |
2009年 | 20篇 |
2008年 | 28篇 |
2007年 | 22篇 |
2006年 | 19篇 |
2005年 | 13篇 |
2004年 | 16篇 |
2003年 | 5篇 |
2002年 | 5篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1989年 | 3篇 |
1988年 | 1篇 |
1981年 | 1篇 |
1979年 | 2篇 |
1977年 | 1篇 |
1973年 | 1篇 |
排序方式: 共有518条查询结果,搜索用时 0 毫秒
81.
82.
83.
Visual processing of one's own body over the course of time: Evidence for the vigilance‐avoidance theory in adolescents with anorexia nervosa? 下载免费PDF全文
84.
Darius A. Rastegar Dinah Applewhite Anika A. H. Alvanzo Christopher Welsh Timothy Niessen Edward S. Chen 《Substance Abuse》2017,38(4):394-400
Background: The standard of care for management of alcohol withdrawal is symptom-triggered treatment using the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar). Many items of this 10-question scale rely on subjective assessments of withdrawal symptoms, making it time-consuming and cumbersome to use. Therefore, there is interest in shorter and more objective methods to assess alcohol withdrawal symptoms. Methods: A 6-item withdrawal scale developed at another institution was piloted. Based on comparison with the CIWA-Ar, this was adapted into a 5-item scale named the Brief Alcohol Withdrawal Scale (BAWS). The BAWS was compared with the CIWA-Ar and a withdrawal protocol utilizing the BAWS was developed. The new protocol was implemented on an inpatient unit dedicated to treating substance withdrawal. Data was collected on the first 3 months of implementation and compared with the 3 months prior to that. Results: A BAWS score of 3 or more predicted CIWA-Ar score ≥8 with a sensitivity of 85.3% and specificity of 65.8%. The demographics of the patients in the 2 time periods were similar: the mean age was 45.9; 70.6% were male; 30.9% received concurrent treatment for opioid withdrawal; and 14.2% were receiving methadone maintenance. During the BAWS phase, patients received significantly less diazepam (mean dose 81.4 vs. 60.3 mg, P < .001). There was no significant difference in length of stay. No patients experienced a seizure, delirium, or required transfer to a higher level of care during any of the 664 admissions in either phase. Conclusions: This simple protocol utilizing a 5-item withdrawal scale performed well in this setting. Its use in other settings, particularly with patients with concurrent medical illnesses or more severe withdrawal, needs to be explored further. 相似文献
85.
This study examines the relationship between physical abuse and periconceptional drinking in women presenting to a mid-Atlantic, urban hospital-based OB/GYN clinic serving a largely indigent population between April 2003 and May 2004. During their first prenatal visit, 308 women completed a screening battery that included the Abuse Assessment Screen (AAS) and measures of alcohol use, including the CAGE, T-ACE, TWEAK, and the PRIME-MD Patient Health Questionnaire (PHQ). Bivariate analyses, including odds ratios (ORs) and 95% confidence intervals (CIs), revealed that women with a history of physical abuse were more likely to report drinking alcohol within the 3 months prior to their prenatal care visit and were significantly more likely to meet criteria for risk drinking on multiple measures. A history of physical abuse appears to be associated with higher self-reported rates of periconceptional drinking in pregnant women. Study findings support the need for assessment of abuse history as a potential risk factor for alcohol use in pregnant women. 相似文献
86.
87.
88.
Shukla S Skoumbourdis AP Walsh MJ Hartz AM Fung KL Wu CP Gottesman MM Bauer B Thomas CJ Ambudkar SV 《Molecular pharmaceutics》2011,8(4):1292-1302
Tasigna (Nilotinib) is a BCR-ABL kinase inhibitor recently approved by the Food and Drug Administration, which is indicated for the treatment of drug-resistant chronic myelogenous leukemia (CML). The efflux of tyrosine kinase inhibitors by ATP-binding cassette (ABC) drug transporters, which actively pump these drugs out of cells utilizing ATP as an energy source, has been linked to the development of drug resistance in CML patients. We report here the synthesis and characterization of a fluorescent derivative of Tasigna to study its interaction with two major ABC transporters, P-glycoprotein (Pgp) and ABCG2, in in vitro and ex vivo assays. A fluorescent derivative of Tasigna, BODIPY FL Tasigna, inhibited the BCR-ABL kinase activity in K562 cells and was also effluxed by Pgp- and ABCG2-expressing cells in both cultured cells and rat brain capillaries expressing Pgp and ABCG2. In addition, [(3)H]-Tasigna was found to be transported by Pgp-expressing polarized LLC-PK1 cells in a transepithelial transport assay. Consistent with these results, both Tasigna and BODIPY FL Tasigna were less effective at inhibiting the phosphorylation of Crkl (a substrate of BCR-ABL kinase) in Pgp- and ABCG2-expressing K562 cells due to their reduced intracellular concentration. Taken together, these data provide evidence that BODIPY FL Tasigna is transported by Pgp and ABCG2, and Tasigna is transported by Pgp. Further, we propose that BODIPY FL Tasigna can potentially be used as a probe for functional analysis of Pgp and ABCG2 in cancer cells and in other preclinical studies. 相似文献
89.
Nadine Beetz Michael D. Harrison Marc Brede Xiangang Zong Michal J. Urbanski Anika Sietmann Jennifer Kaufling Stefan Lorkowski Michel Barrot Mathias W. Seeliger Maria Augusta Vieira-Coelho Pavel Hamet Daniel Gaudet Ondrej Seda Johanne Tremblay Theodore A. Kotchen Mary Kaldunski Rolf Nüsing Bela Szabo Howard J. Jacob Allen W. Cowley Jr. Martin Biel Monika Stoll Martin J. Lohse Ulrich Broeckel Lutz Hein 《The Journal of clinical investigation》2011,121(1):454
90.
Hünermund A Wendel AM Geissinger E Br?cker EB Stoevesandt J 《Journal der Deutschen Dermatologischen Gesellschaft》2011,9(9):666-669
Sweet syndrome (acute febrile neutrophilic dermatosis) is characterized by a dramatic onset of high fever, neutrophilia and typical skin lesions. About 20 % of patients have an associated malignancy, most commonly hematologic diseases. Chronic and paucisymptomatic manifestations of Sweet syndrome may be misdiagnosed or misinterpreted as harmless, resulting in delayed diagnosis. "Atypical" manifestations are especially suspicious for associated malignancies. This is demonstrated by a 39-year old patient with chronic and afebrile disease who was referred to our clinic only after symptoms had persisted for several months. By that point, an underlying nodular lymphocyte predominant Hodgkin's lymphoma had already reached an advanced stage. Skin biopsies revealed dermal infiltrates of histiocytoid cells of myelogenous origin, supporting a diagnosis of histiocytoid Sweet syndrome. Specific cutaneous infiltrates associated with myelogenous leukemia were ruled out. 相似文献